Back to Search
Start Over
The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
- Source :
-
European heart journal [Eur Heart J] 2011 Nov; Vol. 32 (21), pp. 2688-96. Date of Electronic Publication: 2011 Jul 06. - Publication Year :
- 2011
-
Abstract
- Aims: High serum phosphate is linked to cardiovascular morbidity and mortality in the general population. Fibroblast growth factor 23 (FGF-23) is a critical phosphate regulating hormone, potentially reflecting phosphate load better than a single serum phosphate measurement. Recent pioneering echocardiographic studies associated FGF-23 with left-ventricular morphology. However, the association between FGF-23 and left-ventricular function is unknown, prompting us to investigate this relationship in our HOM SWEET HOMe study.<br />Methods and Results: We studied the association between C-terminal FGF-23, coronary artery disease, and left-ventricular function in 885 subjects undergoing elective coronary angiography. Left-ventricular function was assessed with ventriculography. More, pro-brain natriuretic peptide (pro-BNP) plasma levels were measured. The presence of left-ventricular hypertrophy and atrial fibrillation was assessed by electrocardiography. Patients with an ejection fraction <40% had significantly higher FGF-23 levels compared with patients with the ejection fraction >40% (P< 0.001). In multivariable regression analysis, the observed relationship between FGF-23 and left-ventricular function remained significant after adjustment for estimated glomerular filtration rate, presence of left-ventricular hypertrophy, and other confounding variables. In accordance, FGF-23 significantly correlated with pro-BNP plasma levels (r = 0.31; P< 0.001). Prevalent atrial fibrillation was associated with elevated FGF-23 levels, while the presence of coronary artery disease was not.<br />Conclusions: Fibroblast growth factor 23 levels are associated with left-ventricular function and atrial fibrillation even in the absence of renal function impairment. Of note, these cross-sectional data cannot prove causality; therefore, future studies will have to discern whether FGF-23 exerts a direct untoward effect on the myocardium, or rather represents an 'innocent bystander' which reflects a high phosphate burden.
- Subjects :
- Atrial Fibrillation blood
Biomarkers metabolism
Coronary Artery Disease blood
Cross-Sectional Studies
Electrocardiography
Fibroblast Growth Factor-23
Glomerular Filtration Rate physiology
Humans
Hypertrophy, Left Ventricular blood
Hypertrophy, Left Ventricular etiology
Kidney Diseases complications
Kidney Diseases physiopathology
Male
Middle Aged
Natriuretic Peptide, Brain metabolism
Peptide Fragments metabolism
Ventricular Dysfunction, Left blood
Atrial Fibrillation etiology
Calcium Phosphates metabolism
Coronary Artery Disease etiology
Fibroblast Growth Factors metabolism
Ventricular Dysfunction, Left etiology
Subjects
Details
- Language :
- English
- ISSN :
- 1522-9645
- Volume :
- 32
- Issue :
- 21
- Database :
- MEDLINE
- Journal :
- European heart journal
- Publication Type :
- Academic Journal
- Accession number :
- 21733911
- Full Text :
- https://doi.org/10.1093/eurheartj/ehr215